Essential Tremor
233
50
59
110
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
37 trials with published results (16%)
Research Maturity
110 completed trials (47% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.9%
16 terminated out of 233 trials
87.3%
+0.8% vs benchmark
5%
11 trials in Phase 3/4
34%
37 of 110 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 110 completed trials
Clinical Trials (233)
Circadian Adaptive DBS in Essential Tremor
EMBRACE Tremor BiFUS
Human Cognition During Surgery: Stimulation-based and Cholinergic Modulation
Motor Network Physiology
Clinical and Physiological Studies of Tremor Syndromes
Deep Brain Stimulation Surgery for Movement Disorders
Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET)
Impact of Sensory Electrical Stimulation on Sensation and Tremor
Sensory-specific Peripheral Stimulation for Tremor Management
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Deep Brain Stimulation of the Deep Cerebellar Nuclei for Refractory Tremor
Assessment of the Safety and Efficacy of the Felix NeuroAI Wristband in Essential Tremor
Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease
Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS
Pilot Study of the Felix System in Patients With Essential Tremor and Parkinson's Tremor
Coordinated Reset Deep Brain Stimulation for Essential Tremor
Brain Networks and Consciousness
Optimization of VIM Targeting in Essential Tremor Surgery
Decision-making and Emotion Recognition in Essential Tremor